
High-Dose Oral Vancomycin for Treatment of Clostridioides difficile Is Associated With High Risk of Subsequent Cultures With Gram-Negative Organisms
Author(s) -
Mazen S. Bader,
Ali Someili,
Abdulmajeed Alosali,
Amir Hadzic,
Neal Irfan,
Daniela Leto,
Dominik Mertz,
Annie Brooks
Publication year - 2021
Publication title -
infectious diseases in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.145
H-Index - 21
eISSN - 1536-9943
pISSN - 1056-9103
DOI - 10.1097/ipc.0000000000001045
Subject(s) - medicine , vancomycin , odds ratio , antibiotics , confidence interval , retrospective cohort study , clostridioides , gram , microbiology and biotechnology , biology , bacteria , staphylococcus aureus , genetics